InterMed acquires omega-3 strains
This article was originally published in The Tan Sheet
Executive Summary
Natural product firm InterMed Discovery acquires "unique microbial omega-3 fatty acid production strains and related know-how" from the University of Saarland, the Dortmund, Germany-based firm says Aug. 19. IMD says the strains offer a "more favorable ratio" of docosahexaenoic acid and eicosapentaenoic acid. The firm expects to spearhead a research and development initiative with the university to achieve omega-3 formulations allowing for new pharmaceutical, food and supplement product applications. Financial terms were not disclosed